Skip to main content
SpringerLink
Log in

Safety concerns with higher dosage chloroquine in COVID-19 patients

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Borba MGS, et al. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. A Randomized Clinical Trial. JAMA Network Open : 24 Apr 2020. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2020.8857

  • Fihn SD, et al. Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019. JAMA Network Open : 24 Apr 2020. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2020.9035

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Safety concerns with higher dosage chloroquine in COVID-19 patients. Reactions Weekly 1802, 11 (2020). https://doi.org/10.1007/s40278-020-77929-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-77929-x

Search

Navigation